IMPORTANT INFORMATION

Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following information and make the following confirmation each time you seek to access this restricted information. Your confirmation must be true and accurate.

Please enter your country of residence:

IMPORTANT INFORMATION

ACCESS TO THE INFORMATION AND DOCUMENTS ON THIS PORTION OF THE WEBSITE IS RESTRICTED FOR REGULATORY REASONS. YOU ARE REQUESTED TO REVIEW THE FOLLOWING INFORMATION AND MAKE THE FOLLOWING CONFIRMATION EACH TIME YOU SEEK TO ACCESS THIS RESTRICTED INFORMATION. YOUR CONFIRMATION MUST BE TRUE AND ACCURATE.

ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY DARKTRACE PLC (THE "ISSUER") IN GOOD FAITH AND ARE FOR INFORMATION PURPOSES ONLY. THE ISSUER DOES NOT ACCEPT ANY RESPONSIBILITY FOR ANY CONTRAVENTION OF APPLICABLE SECURITIES LAWS AND REGULATIONS BY INDIVIDUALS FOR THE ACCURACY, COMPLETENESS OR FAIRNESS OR USE OF INFORMATION PROVIDED BY SUCH INDIVIDUALS.

THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS IN THE UNITED STATES OR PERSONS RESIDENT OR LOCATED IN AUSTRALIA, CANADA, DUBAI, HONG KONG, JAPAN, SINGAPORE, SWITZERLAND OR ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THE MATERIALS TO WHICH YOU ARE SEEKING ACCESS WOULD BREACH ANY APPLICABLE LAW OR REGULATION.

The release, publication or distribution of the documents or other information contained herein may be restricted by law in certain jurisdictions. Persons into whose possession any of the documents or other information contained herein come should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws or regulations of such jurisdiction.

The information and documents on this portion of the website (a) are intended only for, and may be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to (i) "qualified institutional buyers" (as defined in Rule 144A under the U.S. Securities Act of 1933, as amended (the "US Securities Act") ("QIBs") or (ii) persons resident or physically present outside the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland and resident and physically present in a jurisdiction in which such access, distribution or dissemination would not constitute a violation of the local securities laws or regulations of such jurisdiction, and (b) are not and do not constitute an offer to sell or the solicitation of an offer to buy or acquire, any ordinary shares or other securities of the Issuer in the United States, Australia, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland or any other jurisdiction in which such offer or solicitation would constitute a violation of the local securities laws or regulations of such jurisdiction or would be otherwise unlawful.

Securities may not be sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the US Securities Act. In particular, the securities have not been and will not be registered under the US Securities Act, and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. Any securities will not be registered under or offered in compliance with applicable securities laws of any state, province, territory, county or jurisdiction of the United States, Canada, Dubai, Hong Kong, Japan, Singapore or Switzerland. Accordingly, unless an exemption under the relevant securities law is applicable, any such securities may not be offered, sold, resold, delivered or distributed, directly or indirectly, in or into the United States, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereof in, such jurisdiction. There will be no public offering of securities in the United States. Any securities sold in the United States will be sold only to QIBs in reliance on an exemption from, or transaction not subject to, the registration requirements of the US Securities Act.

The information and documents on this portion of the website are being addressed to and directed at persons in member states of the European Economic Area ("Member States") who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129) ("Qualified Investors"). In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129), as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019, and which is part of UK law by virtue of the European Union (Withdrawal) Act 2018 who are also persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended (the "Order") or who are high net worth bodies corporate, unincorporated associations and partnerships or the trustee of high value trusts falling within Article 49(2)(a) to (d) of the Order, and other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this document relates is available only to Relevant Persons in the United Kingdom and Qualified Investors in Member States, and will only be engaged with such persons. Persons who are not Relevant Persons (in the United Kingdom) or Qualified Investors (in Member States) should not act or rely on this document or any of its contents..

Certain statements contained in documents available on this part of the website constitute forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in documents available on this part of the website that reference past trends or activities should not be taken as a representation that such trends or activities will necessarily continue in the future. You should not place undue reliance on forward-looking statements, which speak only as of the date of the relevant document.

To confirm that:

you have read, understand and agree to comply with all of the restrictions set forth above;
you are either (i) a QIB in the United States or (ii) are resident and physically present in a country outside the United States, Canada, Dubai, Hong Kong, Japan, Singapore or Switzerland or any other jurisdiction in which such distribution or access is unlawful;
you are not resident or physically present in any Member State, unless you are a Qualified Investor;
you are not resident or physically present in the United Kingdom, unless you are a Relevant Person;
it is lawful for you to review and receive copies of the documents on this website;
you agree that you will not transmit or otherwise send any information contained in this website to any person in the United States or to publications with a general circulation in the United States; and
are authorised and permitted to proceed to electronic versions of the information and documents on this portion of the website.

Please select "I confirm" below:

DISCLAIMER – IMPORTANT

We regret that, due to applicable legal restrictions, we are unable to provide you with access to this section of our website.

We apologise for any inconvenience this may cause.

Click here to return to the homepage.

Regulatory News

Form 8.3 - DARKTRACE PLC

RNS Number : 6728R

Barclays PLC

07 June 2024

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				DARKTRACE PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				06 Jun 2024
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				1p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			8,088,416	1.15%	516,691	0.07%
(2)	Cash-settled derivatives:
	and/or controlled:			690,619	0.10%	8,050,790	1.15%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			8,779,035	1.25%	8,567,481	1.22%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
1p ordinary		Purchase		186,582		5.7920 GBP
1p ordinary		Purchase		182,004		5.7982 GBP
1p ordinary		Purchase		101,752		5.8051 GBP
1p ordinary		Purchase		50,000		5.7997 GBP
1p ordinary		Purchase		44,334		5.7998 GBP
1p ordinary		Purchase		30,170		5.7800 GBP
1p ordinary		Purchase		28,000		5.7988 GBP
1p ordinary		Purchase		24,817		5.7977 GBP
1p ordinary		Purchase		23,262		5.8006 GBP
1p ordinary		Purchase		11,580		5.8017 GBP
1p ordinary		Purchase		11,083		5.7980 GBP
1p ordinary		Purchase		5,578		5.8000 GBP
1p ordinary		Purchase		3,517		5.7918 GBP
1p ordinary		Purchase		651		5.8021 GBP
1p ordinary		Purchase		559		5.7991 GBP
1p ordinary		Purchase		113		5.7993 GBP
1p ordinary		Purchase		78		5.7976 GBP
1p ordinary		Purchase		76		5.7960 GBP
1p ordinary		Purchase		75		5.7959 GBP
1p ordinary		Purchase		74		5.7970 GBP
1p ordinary		Purchase		49		5.8005 GBP
1p ordinary		Purchase		23		5.8020 GBP
1p ordinary		Purchase		19		5.8010 GBP
1p ordinary		Sale		85,541		5.7984 GBP
1p ordinary		Sale		62,715		5.7900 GBP
1p ordinary		Sale		39,931		5.7980 GBP
1p ordinary		Sale		30,170		5.7840 GBP
1p ordinary		Sale		15,690		5.7983 GBP
1p ordinary		Sale		11,742		5.7996 GBP
1p ordinary		Sale		9,415		5.7986 GBP
1p ordinary		Sale		5,506		5.7987 GBP
1p ordinary		Sale		5,441		5.8008 GBP
1p ordinary		Sale		4,879		5.7990 GBP
1p ordinary		Sale		4,817		5.7977 GBP
1p ordinary		Sale		3,800		5.8010 GBP
1p ordinary		Sale		2,968		5.7971 GBP
1p ordinary		Sale		1,423		5.8014 GBP
1p ordinary		Sale		1,395		5.7988 GBP
1p ordinary		Sale		1,325		5.7979 GBP
1p ordinary		Sale		1,217		5.7981 GBP
1p ordinary		Sale		1,031		5.7970 GBP
1p ordinary		Sale		1,015		5.8040 GBP
1p ordinary		Sale		751		5.8000 GBP
1p ordinary		Sale		685		5.7930 GBP
1p ordinary		Sale		568		5.8020 GBP
1p ordinary		Sale		76		5.7960 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
1p ordinary		SWAP		Decreasing Long		651	5.8021 GBP
1p ordinary		SWAP		Decreasing Long		676	5.8014 GBP
1p ordinary		SWAP		Decreasing Long		5,087	5.8000 GBP
1p ordinary		SWAP		Decreasing Long		5,817	5.8032 GBP
1p ordinary		SWAP		Decreasing Long		23,262	5.8006 GBP
1p ordinary		SWAP		Decreasing Short		22	5.7979 GBP
1p ordinary		SWAP		Decreasing Short		545	5.8020 GBP
1p ordinary		SWAP		Decreasing Short		731	5.8032 GBP
1p ordinary		SWAP		Decreasing Short		2,968	5.7971 GBP
1p ordinary		CFD		Decreasing Short		20,413	5.7969 GBP
1p ordinary		SWAP		Decreasing Short		25,410	5.7986 GBP
1p ordinary		SWAP		Decreasing Short		51,128	5.7984 GBP
1p ordinary		SWAP		Decreasing Short		62,715	5.7900 GBP
1p ordinary		SWAP		Increasing Long		1,325	5.7979 GBP
1p ordinary		SWAP		Increasing Short		559	5.7991 GBP
1p ordinary		SWAP		Increasing Short		1,303	5.8000 GBP
1p ordinary		SWAP		Increasing Short		3,517	5.7889 GBP
1p ordinary		CFD		Increasing Short		15,427	5.8014 GBP
1p ordinary		CFD		Increasing Short		20,413	5.7969 GBP
1p ordinary		SWAP		Increasing Short		28,000	5.7988 GBP
1p ordinary		SWAP		Increasing Short		44,334	5.7998 GBP
1p ordinary		SWAP		Increasing Short		101,752	5.8051 GBP
1p ordinary		SWAP		Increasing Short		152,363	5.7980 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercising
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				07 Jun 2024
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETBXGDLCSGDGSR

Form 8.3 - Darktrace plc ›

Back to:

Back to Regulatory News ⌃

Form 8.3 - DARKTRACE PLC

Products

Core Coverage

AI Research Centre

Company

Partners

Legal

Products

Core Coverage

AI Research Centre

Company

Partners

Legal

Products

Core Coverage

AI Research Centre

Company

Partners

Legal